An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma

Min Shen; Faming Gong; Pengfei Pang; Xiaochun Meng; Kangshun Zhu; Chun Wu; Jin Wang; Hong Shan; Xintao Shuai
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p3319
Academic Journal
No abstract available.


Related Articles

  • Characterization of polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide nanoparticles (PEG-g-PEI-SPION) as an MRI-visible vector for siRNA delivery in gastric cancer in vitro and in vivo. Chen, Yinting; Lian, Guoda; Liao, Chengde; Wang, Weiwei; Zeng, Linjuan; Qian, Chenchen; Huang, Kaihong; Shuai, Xintao // Journal of Gastroenterology;Jul2013, Vol. 48 Issue 7, p809 

    Background: Gene therapy is a promising therapeutic method but is severely hampered due to its lack of an ideal delivery system. Therefore, in this study, a nonviral and magnetic resonance imaging (MRI) visible vector, polyethylene glycol-grafted polyethylenimine and superparamagnetic iron oxide...

  • An RGD-Modified MRI-Visible Polymeric Vector for Targeted siRNA Delivery to Hepatocellular Carcinoma in Nude Mice. Wu, Chun; Gong, Faming; Pang, Pengfei; Shen, Min; Zhu, Kangshun; Cheng, Du; Liu, Zhihao; Shan, Hong // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    RNA interference (RNAi) has significant therapeutic promise for the genetic treatment of hepatocellular carcinoma (HCC). Targeted vectors are able to deliver small interfering RNA (siRNA) into HCC cells with high transfection efficiency and stability. The tripeptide arginine glycine aspartic...

  • Patents Review in siRNA Delivery for Pulmonary Disorders. Khatri, Nirav I.; Rathi, Mohan N.; Kolte, Atul A.; Kore, Girish G.; Lalan, Manisha S.; Trehan, Sonia; Misra, Ambikanandan R. // Recent Patents on Drug Delivery & Formulation;Apr2012, Vol. 6 Issue 1, p45 

    siRNA inhibits protein expression by degrading complementary mRNA sequence and hence, it is widely applicable for the treatment of various diseases where single or multiple gene knock down is necessary. Due to the severity and lethality of pulmonary diseases, siRNA has been focused for improved...

  • REVIEW ON NON-VIRAL DELIVERY SYSTEMS FOR siRNA. Verma, Vikas; Sangave, Preeti // International Journal of Pharmaceutical Sciences & Research;Feb2014, Vol. 5 Issue 2, p294 

    The emergence of RNAi, has found new horizons in siRNA as drug molecule. This technology offers a great promise in the achieving efficient treatment. There is a demand for designing efficient siRNA delivery systems/ vehicles that can achieve targeted delivery and replicate the invitro success....

  • Nonviral delivery systems for small interfering RNAs. Glebova, K.; Marakhonov, A.; Baranova, A.; Skoblov, M. // Molecular Biology;May2012, Vol. 46 Issue 3, p349 

    RNA interference is now considered to be the most powerful and promising tool for gene-targeted therapy. Several problems are still to be solved for its successful use in medicine. One of the main issues is efficient siRNA delivery. The review considers various types of nonviral siRNA delivery...

  • Therapeutic siRNAs and nonviral systems for their delivery. Glebova, K.; Marakhonov, A.; Baranova, A.; Skoblov, M. // Molecular Biology;May2012, Vol. 46 Issue 3, p335 

    Gene-directed therapy with small interfering RNA (siRNA) has a tremendous potential and will undoubtedly occupy one of the leading positions among other therapeutic methods in the future. The lack of efficient and targeted delivery vectors delays a successful implementation of this method in...

  • Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery. O’Mahony, Aoife M.; Ogier, Julien; Darcy, Raphael; Cryan, John F.; O’Driscoll, Caitriona M. // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Optimising non-viral vectors for neuronal siRNA delivery presents a significant challenge. Here, we investigate a co-formulation, consisting of two amphiphilic cyclodextrins (CDs), one cationic and the other PEGylated, which were blended together for siRNA delivery to a neuronal cell culture...

  • Silencing of Bcl-XL Expression in Human MGC-803 Gastric Cancer Cells by siRNA. Xiao-Yong Lei; Miao Zhong; Lan-Fang Feng; Chun-Yan Yan; Bing-Yang Zhu; Sheng-Song Tang; Duan-Fang Liao // Acta Biochimica et Biophysica Sinica;Aug2005, Vol. 37 Issue 8, p555 

    To investigate the inhibitory effect of the Bcl-XL small interfering RNA (siRNA) on Bcl-XL gene expression in the human gastric cancer cell line MGC-803, green fluorescent protein (GFP) siRNA was constructed and transfected into MGC-803 cells, together with GFP expression vector pTrace SV40. GFP...

  • Nonviral Approach for Targeted Nucleic Acid Delivery. Jafari, M.; Soltani, M.; Naahidi, S.; Karunaratne, D. N.; Chen, P. // Current Medicinal Chemistry;Jan2012, Vol. 19 Issue 2, p197 

    Despite their relatively lower efficiency, nonviral approaches are emerging as safer alternatives in gene therapy to viral vectors. Delivery of nucleic acids to the target site is an important factor for effective gene expression (plasmid DNA) or knockdown (siRNA) with minimal side effects....

  • Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer. Yong Wang; Shujun Gao; Wen-Hui Ye; Ho Sup Yoon; Yi-Yan Yang // Nature Materials;Oct2006, Vol. 5 Issue 10, p791 

    Non-viral gene-delivery systems are safer to use and easier to produce than viral vectors, but their comparatively low transfection efficiency has limited their applications. Co-delivery of drugs and DNA has been proposed to enhance gene expression or to achieve the synergistic/combined effect...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics